Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuankai Shi

Showing results (151-160 of 347) with videos related to

Pageof 35
Sort By:
Asia-Pacific Journal of Clinical Oncology|September 24, 2020
Long-term survival and prognostic analysis of advanced stage follicular lymphoma in the rituximab era: A China single-center retrospective studyYu Zhou, Yan Qin, Xiaohui He, et al.
Thoracic Cancer|February 8, 2018
Heterogeneity-based, multiple mechanisms in the resistance to osimertinib (AZD9291): A case reportYutao Liu, Xuezhi Hao, Xingsheng Hu, et al.
Journal of Hematology & Oncology|January 7, 2017
Different clinical characteristics and treatment strategies for patients with localized sinonasal diffuse large B cell lymphoma and extranodal NK/T cell lymphomaYu Huang, Bo Jia, Shiyu Jiang, et al.
Molecular Diagnosis & Therapy|November 19, 2022
Genetic Profiling of Diffuse Large B-Cell Lymphoma: A Comparison Between Double-Expressor Lymphoma and Non-Double-Expressor LymphomaHaizhu Chen, Yan Qin, Peng Liu, et al.
Journal of Clinical Apheresis|February 3, 2012
Predictive factors for inadequate stem cell mobilization in Chinese patients with NHL and HL: 14-year experience of a single-center studyXiaohong Han, Li Ma, Lingdi Zhao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 1, 2013
Oral topotecan: Bioavailability, pharmacokinetics and impact of ABCG2 genotyping in Chinese patients with advanced cancersNing Li, Yuanyuan Song, Ping Du, et al.
Frontiers in Immunology|October 5, 2023
Efficacy and safety of immunotherapy combined with single-agent chemotherapy as second- or later-line therapy for metastatic non-small cell lung cancerDongna Chen, Lin Li, Mingzhao Wang, et al.
The Oncologist|April 7, 2019
Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell LymphomaYing Han, Jianliang Yang, Peng Liu, et al.
Translational Lung Cancer Research|January 25, 2021
Investigation on the potential of circulating tumor DNA methylation patterns as prognostic biomarkers for lung squamous cell carcinomaYutao Liu, Yu Feng, Ting Hou, et al.
Chinese Medical Journal|February 23, 2022
Efficacy and safety of obinutuzumab for the first-line treatment of follicular lymphoma: a subgroup analysis of Chinese patients enrolled in the phase III GALLIUM studyXiaonan Hong, Yuqin Song, Yuankai Shi, et al.
Pageof 35

Showing results (151-160 of 347) with videos related to

Sort By:
Pageof 35
Asia-Pacific Journal of Clinical Oncology|September 24, 2020
Long-term survival and prognostic analysis of advanced stage follicular lymphoma in the rituximab era: A China single-center retrospective studyYu Zhou, Yan Qin, Xiaohui He, et al.
Thoracic Cancer|February 8, 2018
Heterogeneity-based, multiple mechanisms in the resistance to osimertinib (AZD9291): A case reportYutao Liu, Xuezhi Hao, Xingsheng Hu, et al.
Journal of Hematology & Oncology|January 7, 2017
Different clinical characteristics and treatment strategies for patients with localized sinonasal diffuse large B cell lymphoma and extranodal NK/T cell lymphomaYu Huang, Bo Jia, Shiyu Jiang, et al.
Molecular Diagnosis & Therapy|November 19, 2022
Genetic Profiling of Diffuse Large B-Cell Lymphoma: A Comparison Between Double-Expressor Lymphoma and Non-Double-Expressor LymphomaHaizhu Chen, Yan Qin, Peng Liu, et al.
Journal of Clinical Apheresis|February 3, 2012
Predictive factors for inadequate stem cell mobilization in Chinese patients with NHL and HL: 14-year experience of a single-center studyXiaohong Han, Li Ma, Lingdi Zhao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 1, 2013
Oral topotecan: Bioavailability, pharmacokinetics and impact of ABCG2 genotyping in Chinese patients with advanced cancersNing Li, Yuanyuan Song, Ping Du, et al.
Frontiers in Immunology|October 5, 2023
Efficacy and safety of immunotherapy combined with single-agent chemotherapy as second- or later-line therapy for metastatic non-small cell lung cancerDongna Chen, Lin Li, Mingzhao Wang, et al.
The Oncologist|April 7, 2019
Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell LymphomaYing Han, Jianliang Yang, Peng Liu, et al.
Translational Lung Cancer Research|January 25, 2021
Investigation on the potential of circulating tumor DNA methylation patterns as prognostic biomarkers for lung squamous cell carcinomaYutao Liu, Yu Feng, Ting Hou, et al.
Chinese Medical Journal|February 23, 2022
Efficacy and safety of obinutuzumab for the first-line treatment of follicular lymphoma: a subgroup analysis of Chinese patients enrolled in the phase III GALLIUM studyXiaonan Hong, Yuqin Song, Yuankai Shi, et al.
Pageof 35